The National Parkinson Foundation (NPF) has awarded more than $1 million for clinical research projects. Through NPF's individual investigators awards program, it is supporting work to advance three key areas of Parkinson's disease: an advanced biomarker study, a clinical trial to treat memory impairment and a study of the effectiveness of a treatment for sleep apnea.
"Each of these projects can have an immediate impact on the lives of Parkinson's disease patients, from a novel approach to developing a new biomarker to treatments for two important non-motor symptoms," said Joyce Oberdorf, NPF's president and CEO. "Both sleep issues and cognition are important, but often overlooked, contributors to the burden of the disease."
Under the direction of the Clinical and Scientific Advisory Board, NPF supports leading-edge research conducted by top neurological experts at its 43 Centers of Excellence worldwide. These awards will support investigations at Centers of Excellence in the U.S. and Canada: